Oncimmune Holdings plc
ONC.L · LSE
8/31/2024 | 2/29/2024 | 8/31/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,399 | -£1,099 | -£2,095 | -£4,056 |
| Dep. & Amort. | £109 | £154 | £0 | £780 |
| Deferred Tax | £0 | £0 | £110 | -£110 |
| Stock-Based Comp. | £0 | £0 | £0 | -£1,314 |
| Change in WC | £391 | -£484 | -£269 | £246 |
| Other Non-Cash | £698 | -£751 | -£1,423 | £1,609 |
| Operating Cash Flow | -£1,201 | -£2,180 | -£3,946 | -£2,845 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£5 | -£4 | -£6 | -£25 |
| Net Acquisitions | £0 | £0 | £149 | -£110 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £1,170 | £0 | £10,908 | £667 |
| Investing Cash Flow | £1,165 | -£4 | £11,051 | £532 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | -£4,885 | £0 |
| Stock Issued | £9 | -£4 | -£4 | £2,099 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£31 | -£45 | -£103 | -£122 |
| Financing Cash Flow | -£22 | -£49 | -£4,992 | £1,977 |
| Forex Effect | £0 | £0 | £316 | -£1,414 |
| Net Chg. in Cash | £0 | -£2,298 | £2,429 | -£1,750 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £911 | £3,209 | £780 | £2,530 |
| End Cash | £846 | £911 | £3,209 | £780 |
| Free Cash Flow | -£1,206 | -£2,184 | -£3,952 | -£2,870 |